|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.61 USD | +1.65% |
|
-0.64% | +271.13% |
| Jul. 01 | Nutex Health Inc., Q1 2025 Earnings Call, May 14, 2025 | |
| Jun. 30 | Nutex Health Inc.(NasdaqCM:NUTX) added to Russell 3000 Growth Index | CI |
| Capitalization | 637M 544M 507M 472M 871M 54.63B 969M 6.08B 2.32B 25.58B 2.39B 2.34B 93.82B | P/E ratio 2025 * |
21.4x | P/E ratio 2026 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise value | 637M 544M 507M 472M 871M 54.63B 969M 6.08B 2.32B 25.58B 2.39B 2.34B 93.82B | EV / Sales 2025 * |
0.86x | EV / Sales 2026 * | 0.82x |
| Free-Float |
60.95% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Nutex Health Inc.
More recommendations
More press releases
| 1 day | +1.65% | ||
| 1 week | -0.64% | ||
| Current month | -5.53% | ||
| 1 month | -2.62% | ||
| 3 months | -10.92% | ||
| 6 months | +280.86% | ||
| Current year | +271.13% |
| 1 week | 108.17 |  | 140.42 |
| 1 month | 106.92 | | 140.42 |
| Current year | 28.82 | | 184.28 |
| 1 year | 5.25 | | 184.28 |
| 3 years | 4.16 | | 649.5 |
| 5 years | 4.16 | | 7,920 |
| 10 years | 4.16 | | 7,920 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Vo
CEO | Chief Executive Officer | 52 | 2022-03-31 |
| President | 53 | 2022-03-31 | |
Jon Bates
DFI | Director of Finance/CFO | 55 | 2022-06-29 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2022-03-31 | |
Mitchell Creem
BRD | Director/Board Member | 64 | 2022-03-31 |
Thomas Vo
CHM | Chairman | 52 | 2022-03-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 9 M€ | +5.34% | - | |
| 0% | 22 M€ | +2.65% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.65% | -0.64% | +2,365.62% | -72.96% | 653M | ||
| -0.59% | -0.14% | +18.44% | +122.01% | 91.01B | ||
| -1.28% | -3.93% | +11.29% | -31.60% | 83.01B | ||
| -0.66% | -1.06% | +44.57% | +45.07% | 27.79B | ||
| -0.75% | -1.49% | -6.36% | +38.74% | 24.73B | ||
| -1.58% | -4.69% | +21.03% | +2.88% | 21.23B | ||
| -1.96% | -4.99% | +17.14% | +23.62% | 19.14B | ||
| +1.20% | +2.48% | +31.42% | +225.46% | 16.13B | ||
| -1.45% | -3.38% | +27.72% | -2.82% | 16.1B | ||
| -2.56% | -6.02% | +35.96% | +233.21% | 14.19B | ||
| Average | -0.80% | -1.47% | +256.68% | +58.36% | 31.4B | |
| Weighted average by Cap. | -0.98% | -1.28% | +23.82% | +57.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 743M 636M 592M 551M 1.02B 63.78B 1.13B 7.09B 2.71B 29.86B 2.79B 2.73B 110B | 775M 663M 617M 574M 1.06B 66.51B 1.18B 7.4B 2.83B 31.14B 2.91B 2.85B 114B |
| Net income | 32.94M 28.17M 26.24M 24.4M 45.09M 2.83B 50.11M 314M 120M 1.32B 124M 121M 4.85B | 43.51M 37.2M 34.65M 32.23M 59.56M 3.73B 66.19M 415M 159M 1.75B 163M 160M 6.41B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
830
Calendar
Jul. 13
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 114.61 $ | -2.55% | 196,035 |
| 25-07-10 | 117.61 $ | +1.65% | 225,632 |
| 25-07-09 | 115.70 $ | -16.06% | 1,080,002 |
| 25-07-08 | 137.83 $ | +9.62% | 350,662 |
| 25-07-07 | 125.73 $ | +6.22% | 282,581 |
End-of-day quote Nasdaq, July 09, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
114.61USD
Average target price
248.33USD
Spread / Average Target
+116.68%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NUTX Stock
Select your edition
All financial news and data tailored to specific country editions
